Viewing Study NCT00618202


Ignite Creation Date: 2025-12-25 @ 4:03 AM
Ignite Modification Date: 2026-01-09 @ 1:41 AM
Study NCT ID: NCT00618202
Status: COMPLETED
Last Update Posted: 2018-01-23
First Post: 2008-01-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions
Sponsor: Roxane Laboratories
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module